| Washington University in St. Louis | |
|---|---|
| WashU Logo | |
| Location | St. Louis, Missouri, USA |
| Type | Private Research University |
| Founded | 1853 |
| Website | wustl.edu |
| Focus Areas | Alzheimer's Disease, Parkinson's Disease, ALS, Dementia, Neuroimaging, Genetics |
| Medical School | Washington University School of Medicine |
Washington University In St. Louis is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Washington University in St. Louis (WashU) is one of the world's leading private research universities, founded in 1853. Its School of Medicine is consistently ranked among the top in the nation for neuroscience and neurodegeneration research. The university's Knight Alzheimer's Disease Research Center (ADRC) is one of the original NIH-funded ADRCs and has been instrumental in defining the preclinical and prodromal stages of Alzheimer's disease1.
WashU's neuroscience community benefits from close integration between the School of Medicine, the Division of Biological Sciences, and the School of Engineering, enabling multidisciplinary approaches to neurodegeneration.
The Knight ADRC, directed by Dr. John Morris, has defined the preclinical Alzheimer's disease cascade and developed biomarker criteria now used worldwide. The center contributes to the Alzheimer's Clinical Trials Consortium and has pioneered cerebrospinal fluid and PET biomarker discovery2.
The Hope Center focuses on understanding the basic biology of neurological disorders, including Alzheimer's, Parkinson's, ALS, and multiple sclerosis. Research spans from molecular mechanisms to translational therapeutics3.
WashU leads the international DIAN observational study and clinical trials for individuals with autosomal dominant Alzheimer's disease mutations, providing unique insights into disease pathogenesis decades before symptom onset.
| Disease | Research Intensity |
|---|---|
| Alzheimer's Disease | Very High |
| Parkinson's Disease | High |
| ALS | Moderate |
| Frontotemporal Dementia | Moderate |
| Huntington's Disease | Low |
WashU offers extensive training through the Neuroscience Program, the MD/PhD Program, and the Postdoctoral Training Program in neurodegeneration.
The study of Washington University In St. Louis has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
WashU researchers have made landmark contributions: